Tennessee Code 63-7-130 – Suspension for failure to collaborate – On-site supervision of healthcare prescriber subject of disciplinary action for conduct related to improper prescribing or diversion of controlled substance
Person: includes a corporation, firm, company or association. See Tennessee Code 1-3-105
State: when applied to the different parts of the United States, includes the District of Columbia and the several territories of the United States. See Tennessee Code 1-3-105
(1) Failure by a person licensed under and required by this chapter to collaborate with a physician for any act within the person’s licensed scope of practice constitutes a threat to the public health, safety, and welfare and imperatively requires emergency action by the board.(2) Notwithstanding any law, if the board learns that a person licensed under this chapter and subject to a requirement to collaborate with a physician for any act within the person’s licensed scope of practice has failed to comply with the collaboration requirement, then the board chair, or the chair’s designee, shall direct the administrative staff to automatically and immediately, without further action by the board, suspend the person’s license until the board receives sufficient proof that the person is in compliance with the collaboration requirements of this chapter.(3) The licensure sanction authorized by this subsection (a) is supplementary to, and does not limit, the authority of the board to take other disciplinary action against a licensee the board determines to be in violation of this chapter.(b) If a healthcare prescriber licensed under this chapter is the subject of a disciplinary action by the board for conduct related to improper prescribing or diversion of a controlled substance, but retains an active license with prescribing authority following the disciplinary action, then the healthcare prescriber shall not prescribe a controlled substance in this state unless the healthcare prescriber is working in collaboration with a physician who is physically present at the same practice site and licensed to prescribe controlled substances in this state. The board shall determine the period of time that a healthcare prescriber is subject to the on-site supervision requirement of this subsection (b), which must not be less than two (2) years.
